Selected research
Market Structure
Global HMO Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global HMO Infant Formula market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for HMO Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for HMO Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for HMO Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for HMO Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of HMO Infant Formula include Abbott, Mead Johnson（Reckitt）, Nestlé（Wyeth Nutrition）, Danone (Aptamil), FrieslandCampina (Friso), Biostime and Yili Group (Ausnutria Dairy), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global HMO Infant Formula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of HMO Infant Formula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents HMO Infant Formula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the HMO Infant Formula market size, projected growth trends, production technologies, key applications, and end-use industries.
HMO Infant Formula Segment by Company
Abbott
Mead Johnson（Reckitt）
Nestlé（Wyeth Nutrition）
Danone (Aptamil)
FrieslandCampina (Friso)
Biostime
Yili Group (Ausnutria Dairy)
HMO Infant Formula Segment by Type
2'-Fucosyllactose (2'-FL)
Others
HMO Infant Formula Segment by Application
Online Channel
Specialty Store
Supermarket
Others
HMO Infant Formula Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HMO Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HMO Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HMO Infant Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the HMO Infant Formula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HMO Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HMO Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of HMO Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 2'-Fucosyllactose (2'-FL)
- Others
Applications
- Online Channel
- Specialty Store
- Supermarket
- Others
Companies covered
- Abbott
- Mead Johnson（Reckitt）
- Nestlé（Wyeth Nutrition）
- Danone (Aptamil)
- FrieslandCampina (Friso)
- Biostime
- Yili Group (Ausnutria Dairy)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global HMO Infant Formula Market Size, 2021 VS 2025 VS 2032
- 1.3 Global HMO Infant Formula Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global HMO Infant Formula Sales Estimates and Forecasts (2021-2032)
- 1.5 Global HMO Infant Formula Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global HMO Infant Formula Market Dynamics
- 2.1 HMO Infant Formula Industry Trends
- 2.2 HMO Infant Formula Industry Drivers
- 2.3 HMO Infant Formula Industry Opportunities and Challenges
- 2.4 HMO Infant Formula Industry Restraints
3 HMO Infant Formula Market by Manufacturers
- 3.1 Global HMO Infant Formula Revenue by Manufacturers (2021-2026)
- 3.2 Global HMO Infant Formula Sales by Manufacturers (2021-2026)
- 3.3 Global HMO Infant Formula Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global HMO Infant Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global HMO Infant Formula Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global HMO Infant Formula Manufacturers, Product Type & Application
- 3.7 Global HMO Infant Formula Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global HMO Infant Formula Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 HMO Infant Formula Players Market Share by Revenue in 2025
- 3.8.3 2025 HMO Infant Formula Tier 1, Tier 2, and Tier 3
4 HMO Infant Formula Market by Type
- 4.1 HMO Infant Formula Type Introduction
- 4.1.1 2'-Fucosyllactose (2'-FL)
- 4.1.2 Others
- 4.2 Global HMO Infant Formula Sales by Type
- 4.2.1 Global HMO Infant Formula Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global HMO Infant Formula Sales by Type (2021-2032)
- 4.2.3 Global HMO Infant Formula Sales Market Share by Type (2021-2032)
- 4.3 Global HMO Infant Formula Revenue by Type
- 4.3.1 Global HMO Infant Formula Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global HMO Infant Formula Revenue by Type (2021-2032)
- 4.3.3 Global HMO Infant Formula Revenue Market Share by Type (2021-2032)
5 HMO Infant Formula Market by Application
- 5.1 HMO Infant Formula Application Introduction
- 5.1.1 Online Channel
- 5.1.2 Specialty Store
- 5.1.3 Supermarket
- 5.1.4 Others
- 5.2 Global HMO Infant Formula Sales by Application
- 5.2.1 Global HMO Infant Formula Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global HMO Infant Formula Sales by Application (2021-2032)
- 5.2.3 Global HMO Infant Formula Sales Market Share by Application (2021-2032)
- 5.3 Global HMO Infant Formula Revenue by Application
- 5.3.1 Global HMO Infant Formula Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global HMO Infant Formula Revenue by Application (2021-2032)
- 5.3.3 Global HMO Infant Formula Revenue Market Share by Application (2021-2032)
6 Global HMO Infant Formula Sales by Region
- 6.1 Global HMO Infant Formula Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global HMO Infant Formula Sales by Region (2021-2032)
- 6.2.1 Global HMO Infant Formula Sales by Region (2021-2026)
- 6.2.2 Global HMO Infant Formula Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America HMO Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America HMO Infant Formula Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe HMO Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe HMO Infant Formula Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific HMO Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific HMO Infant Formula Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa HMO Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa HMO Infant Formula Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global HMO Infant Formula Revenue by Region
- 7.1 Global HMO Infant Formula Revenue by Region
- 7.1.1 Global HMO Infant Formula Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global HMO Infant Formula Revenue by Region (2021-2026)
- 7.1.3 Global HMO Infant Formula Revenue by Region (2027-2032)
- 7.1.4 Global HMO Infant Formula Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America HMO Infant Formula Revenue (2021-2032)
- 7.2.2 North America HMO Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe HMO Infant Formula Revenue (2021-2032)
- 7.3.2 Europe HMO Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific HMO Infant Formula Revenue (2021-2032)
- 7.4.2 Asia-Pacific HMO Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa HMO Infant Formula Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa HMO Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott HMO Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott HMO Infant Formula Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 Mead Johnson（Reckitt）
- 8.2.1 Mead Johnson（Reckitt） Company Information
- 8.2.2 Mead Johnson（Reckitt） Business Overview
- 8.2.3 Mead Johnson（Reckitt） HMO Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mead Johnson（Reckitt） HMO Infant Formula Product Portfolio
- 8.2.5 Mead Johnson（Reckitt） Recent Developments
- 8.3 Nestlé（Wyeth Nutrition）
- 8.3.1 Nestlé（Wyeth Nutrition） Company Information
- 8.3.2 Nestlé（Wyeth Nutrition） Business Overview
- 8.3.3 Nestlé（Wyeth Nutrition） HMO Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Nestlé（Wyeth Nutrition） HMO Infant Formula Product Portfolio
- 8.3.5 Nestlé（Wyeth Nutrition） Recent Developments
- 8.4 Danone (Aptamil)
- 8.4.1 Danone (Aptamil) Company Information
- 8.4.2 Danone (Aptamil) Business Overview
- 8.4.3 Danone (Aptamil) HMO Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Danone (Aptamil) HMO Infant Formula Product Portfolio
- 8.4.5 Danone (Aptamil) Recent Developments
- 8.5 FrieslandCampina (Friso)
- 8.5.1 FrieslandCampina (Friso) Company Information
- 8.5.2 FrieslandCampina (Friso) Business Overview
- 8.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 FrieslandCampina (Friso) HMO Infant Formula Product Portfolio
- 8.5.5 FrieslandCampina (Friso) Recent Developments
- 8.6 Biostime
- 8.6.1 Biostime Company Information
- 8.6.2 Biostime Business Overview
- 8.6.3 Biostime HMO Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Biostime HMO Infant Formula Product Portfolio
- 8.6.5 Biostime Recent Developments
- 8.7 Yili Group (Ausnutria Dairy)
- 8.7.1 Yili Group (Ausnutria Dairy) Company Information
- 8.7.2 Yili Group (Ausnutria Dairy) Business Overview
- 8.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio
- 8.7.5 Yili Group (Ausnutria Dairy) Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 HMO Infant Formula Value Chain Analysis
- 9.1.1 HMO Infant Formula Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 HMO Infant Formula Production Mode & Process
- 9.2 HMO Infant Formula Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 HMO Infant Formula Distributors
- 9.2.3 HMO Infant Formula Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst